Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FX25B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,262
Award facts
- Contract value 100% obligated
- $26,261.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $26,261.81 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its critical role in supplying pharmaceutical products and medical supplies to defense and veteran healthcare systems. The parent IDC enables the company to deliver a wide range of medical commodities including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. Through this contract structure, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA is currently planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, reflecting the strategic importance of reliable pharmaceutical supply chains to federal military and healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FX25B?
SPE2DB25FX25B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FX25B worth?
The government has obligated $26,262 on SPE2DB25FX25B.
Is contract SPE2DB25FX25B an order under another contract?
Yes. SPE2DB25FX25B is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX25B competed?
The extent of competition for SPE2DB25FX25B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award